首页 | 本学科首页   官方微博 | 高级检索  
检索        


Neurological and psychiatric tolerability of rilpivirine (TMC278) vs. efavirenz in treatment‐naïve,HIV‐1‐infected patients at 48 weeks
Authors:AM Mills  A Antinori  B Clotet  J Fourie  G Herrera  C Hicks  JV Madruga  S Vanveggel  M Stevens  K Boven  ECHO and THRIVE study groups
Institution:1. Anthony Mills MD Inc., , Los Angeles, CA, USA;2. National Institute for Infectious Diseases ‘Lazzaro Spallanzani’ IRCCS, , Rome, Italy;3. University Hospital Germans Trias i Pujol and irsiCaixa Foundation, UAB, , Barcelona, Spain;4. Dr J Fourie Medical Centre, , Dundee, KwaZulu Natal, South Africa;5. Hospital CIMA San Jose, , San Jose, Costa Rica;6. Division of Infectious Diseases, Duke University Medical Center, , Durham, NC, USA;7. Centro de Referência e Treinamento DST/AIDS, , S?o Paulo, Brazil;8. Janssen Infectious Diseases BVBA, , Beerse, Belgium;9. Janssen Research & Development, LLC, , Titusville, NJ, USA
Abstract:
Keywords:adverse events  central nervous system  efavirenz  neuropsychiatric  rilpivirine  safety
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号